Evidence map›Paper›PMID 41098668›Full record

ArticleRevista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia2025

Challenges and recommendations of vaccination in immunosuppression.

Caroline Alves de Oliveira Martins, Isabella Ballalai, Juarez Cunha, Susana Aidé

Abstract read
In one paragraph

Article in Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Caroline Alves de Oliveira MartinsUniversidade Federal Fluminense Rio de JaneiroRJ Brazil 1-Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil; Comissão Nacional Especializada de Vacinas da Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo), Brazil.ORCID https://orcid.org/0000-0002-7207-7969
Isabella BallalaiFederação Brasileira das Associações de Ginecologia e Obstetrícia Brazil 2-Comissão Nacional Especializada de Vacinas da Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo); Sociedade Brasileira de Imunizações (SBIm), Brazil.ORCID https://orcid.org/0000-0001-6285-9257
Juarez CunhaFederação Brasileira das Associações de Ginecologia e Obstetrícia Brazil 3-Comissão Nacional Especializada de Vacinas da Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo); Brasileira de Imunizações (SBIm), Brazil.ORCID https://orcid.org/0000-0002-4340-270X
Susana AidéUniversidade Federal Fluminense Rio de JaneiroRJ Brazil 4-Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil; Comissão Nacional Especializada de Vacinas da Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo), Brazil.ORCID https://orcid.org/0000-0002-4212-0022

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•Address the types of immunodeficiency and the greater susceptibility to severe infections compared to the general population, as well as a less efficient response to vaccine stimuli. •Provide information on the negative impacts of infections on the health of immunodeficient individuals and their complications. •Provide knowledge of studies on the efficacy and safety of vaccines in the immunosuppressed population. •Clarify which vaccines should be indicated, the best time to administer them, and when to revaccinate. •Update gynecologists and obstetricians on the vaccination schedule for this population and on the position of the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) regarding the vaccines made available by the National Immunization Program, including by the Reference Centers for Special Immunobiologicals (Portuguese acronym: CRIEs) and private vaccination services.

Indexed as

Immunocompromised HostVaccinationFemaleHumansImmunization SchedulePractice Guidelines as Topic

Identifiers

PMID41098668
PMCPMC12520726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.